Prevalence of thrombocytopenia, anti–platelet factor 4 antibodies and D‐dimer elevation in Thai people After ChAdOx1 nCoV‐19 vaccination-Reference-Cited by-同舟云学术

Prevalence of thrombocytopenia, anti–platelet factor 4 antibodies and D‐dimer elevation in Thai people After ChAdOx1 nCoV‐19 vaccination

Published:2021-08 Issue:6 Volume:5 Page:
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Res Pract Thromb Haemost

Author:

Uaprasert Noppacharn¹²^ORCID,Watanaboonyongcharoen Phandee³,Vichitratchaneekorn Rattaporn³,Trithiphen Sasinipa¹,Akkawat Benjaporn¹²,Sukperm Autcharaporn¹²,Tongbai Thanisa⁴,Jantarabenjakul Watsamon⁵,Paitoonpong Leilani⁶,Rojnuckarin Ponlapat¹²^ORCID

Affiliation:

1. Department of Medicine Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial HospitalThai Red Cross Society Bangkok Thailand

2. Research Unit in Translational Hematology Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial HospitalThai Red Cross Society Bangkok Thailand

3. Department of Laboratory Medicine Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial HospitalThai Red Cross Society Bangkok Thailand

4. Department of Radiology Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial HospitalThai Red Cross Society Bangkok Thailand

5. Division of Infectious Diseases Department of Pediatrics Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial HospitalThai Red Cross Society Bangkok Thailand

6. Division of Infectious Diseases Department of Medicine Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial HospitalThai Red Cross Society Bangkok Thailand

Funder

King Chulalongkorn Memorial Hospital

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rth2.12580

Reference20 articles.

1. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study

2. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

3. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials